Evolvence Capital, a leading global private equity investment house headquartered in the Middle East, is helping to bring together the leading players in private equity in Asia, Europe and the US to discuss the most important issues affecting the rapidly evolving private equity and venture capital landscape, with its co-sponsorship of the SuperReturn Asia 2006 conference, which is being held in Hong Kong, 12-13th September 2006.
Jay Jegannathan, Managing Director Evolvence India Fund, will be part of a discussion panel on the investor perspective on Asia. In addition, Hari Buggana & Dr. Anula Jayasuriya, the Managing Directors of Evolvence India Life Sciences Fund, will make a presentation on the opportunities in the Life Science space in Asia with a focus on India.
Evolvence Capital, which is headquartered in Dubai, United Arab Emirates, has offices in New Delhi and US operations in New York. It was founded by Mr Khaled Al-Muhairy in 2000. The company focuses on incubating private equity funds globally, with a focus on India and the GCC region. With US$750 million assets under Management and an international team in place, the firm is in prime position for further growth.
Evolvence Capital has launched several funds and most recently, launched the US$150 million Evolvence India Life Sciences Fund, a private equity fund that provides growth capital to Indian pharmaceutical and biotechnology companies. The Fund was created in response to strong demand for long term capital from small to mid-sized pharmaceutical, biotechnology, and contract research & manufacturing businesses in India.
Mr. Khaled Al-Muhairy, the Founder and CEO of Evolvence Capital said, “We are delighted to sponsor this prestigious event and to be able to share with delegates our expertise on the India private equity market and life science space. The event provides an excellent opportunity to interact with the international investor community, exchange thoughts on global business themes and discuss investment ideas to address the same”.
